Video Insights
Video Insights
Advertisement
Amar Kishan, MDProstate Cancer | March 24, 2023
Amar Kishan, MD gives an overview of the MIRAGE trial that compared MRI-guided and CT-guided SBRT for prostate cancer.
View More
Brian Rini, MD, FASCOVideo Insights | March 16, 2023
In the final segment of a debate series, Brian Rini, MD, and Monty Pal, MD, debate RCC adjuvant therapeutic options.
Brian Rini, MD, FASCOVideo Insights | March 15, 2023
In the second segment of a debate series, Drs. Rini and Pal address kidney cancer clinical trials of interest.
Brian Rini, MD, FASCOVideo Insights | March 14, 2023
In a debate series between Brian Rini, MD, and Monty Pal, MD, they discuss frontline RCC treatment options.
Rana McKay, MDAdvanced Renal Cell Carcinoma | March 8, 2023
Dr. McKay explains how radiation therapy and modalities fit into the treatment paradigm for RCC.
Rana McKay, MDAdvanced Renal Cell Carcinoma | March 8, 2023
Dr. McKay summarizes the novel therapies or optimal sequencing patterns that are close to entering the mRCC treatment space.
Rana McKay, MDAdvanced Renal Cell Carcinoma | March 8, 2023
Dr. McKay offers an overview of the second-line and later-line therapy options after progression for metastatic RCC.
Rana McKay, MDAdvanced Renal Cell Carcinoma | March 8, 2023
Dr. McKay highlights the results of a few studies that support the use of frontline immunotherapy for favorable-risk mRCC.
Rana McKay, MDAdvanced Renal Cell Carcinoma | March 8, 2023
Dr. Rana McKay details how advanced or mRCC is currently managed and how the treatment paradigm has evolved since 2018.
Phouc T. Tran, MD, PhDASCO GU Symposium 2023 | February 24, 2023
Phouc Tran, MD, PhD, highlights the challenges of accurate risk stratification for newly diagnosed localized prostate cancer.
Siddharth Ramanathan and Savitha Balaraman, MDProstate Cancer | February 23, 2023
Siddharth Ramanathan and Savitha Balaraman, MD, highlight an onsite genetic testing protocol for newly diagnosed with PC.
Howard Korman, MD, and Savitha Balaraman, MDProstate Cancer | February 23, 2023
Drs. Howard Korman and Savitha Balaraman describe the importance of genetic testing for patients newly diagnosed with PC.
Daniel M. Geynisman, MDASCO GU Symposium 2023 | February 23, 2023
Daniel M. Geynisman, MD, explains the results and utility of the RETAIN trial for bladder sparing in patients with MIBC.
Scott Tagawa, MD, MS, FACPRLT-PSMA | February 22, 2023
Scott Tagawa, MD, MS, FACP, shares what needs to happen for radionuclide therapy to make its way into the community setting.
Scott Tagawa, MD, MS, FACPRLT-PSMA | February 22, 2023
Scott Tagawa, MD, MS, FACP, highlights what clinicians must know prior to recommending Lutetium-177–PSMA-617 to patients.
Scott Tagawa, MD, MS, FACPNext-Generation Imaging | February 22, 2023
Scott Tagawa, MD, MS, FACP, explains the distinct ways in which PSMA imaging compares to standard cross-sectional imaging.
Michael B. Atkins, MDASCO GU Symposium 2023 | February 18, 2023
Michael Atkins, MD, discusses TFS outcomes from the phase II study and argues for immunotherapy in favorable-risk patients.
Steven Campbell, MD, PhDASCO GU Symposium 2023 | February 18, 2023
Steven Campbell, MD, PhD, overviews the surgical options available for patients with localized renal cell carcinoma.
Andrea Necchi, MDASCO GU Symposium 2023 | February 18, 2023
Andrea Necchi, MD, speculates on the applicability of pembrolizumab monotherapy for BCG-unresponsive NMIBC.
Chadi Nabhan, MD, MBA, FACPASCO GU Symposium 2023 | February 18, 2023
Chadi Nabhan, MD, MBA, FACP, shares how precision medicine and personalized care have emerged as themes at this Symposium.
Advertisement
Advertisement
Advertisement